Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

(5) Primary outcome measures include any related measures of CIPN. (1) Studies comparing different types of acupuncture. (2) Studies with a total sample size of less than 10. (3) Conference abstracts, ...

Multivariable analysis using the CART model was tuned using 10-fold cross-validation to identify baseline predictors for CIPN throughout chemotherapy. A receiver operating characteristic curve ...

1 Translational Pharmacokinetics/Pharmacodynamics Group (tPKPD), Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden 2 Pharmacy and ...

The first volume of her frank autobiography is a testament to resilience, chronicling a grim childhood and the brazen path to stardom, with and without Sonny. By Alexandra Jacobs To fully unders ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect to chemotherapy treatment. It can cause symptoms that range from sensitivity to touch and numbness to neuropathic pain in ...

In this review, I will consider the clinicopathological aspects of the various patterns of diabetic neuropathy, starting with length-dependent diabetic polyneuropathy (LDDP), which is by far the ...

a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), announced today that The ...

The emphasis of management of diabetic neuropathy remains prevention by glycemic control. The purpose of this article is to review the epidemiology, classification, pathology, and treatment of ...